Related Experiment Video
Updated: Jun 26, 2026
Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
The genetics of malignant melanoma: lessons from mouse and man
1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA. Lynda_Chin@dfci.harvard.edu
Abstract:
Therapeutic resistance and proclivity for metastasis are hallmarks of malignant melanoma. Genetic, epidemiological and genomic investigations are uncovering the spectrum of stereotypical mutations that are associated with melanoma and how these mutations relate to risk factors such as ultraviolet exposure. The ability to validate the pathogenetic relevance of these mutations in the mouse, coupled with advances in rational drug design, has generated optimism for the development of effective prevention programmes, diagnostic measures and targeted therapeutics in the near future.
Insights
Malignant melanoma is characterized by therapeutic resistance and metastasis. Research is identifying key mutations linked to risk factors like UV exposure, paving the way for new melanoma treatments.
Area of Science:
- Oncology
- Genetics
- Dermatology
Background:
- Malignant melanoma exhibits therapeutic resistance and metastasis.
- Understanding genetic mutations and risk factors like UV exposure is crucial.
Purpose of the Study:
- To investigate the spectrum of mutations associated with melanoma.
- To correlate these mutations with risk factors such as ultraviolet exposure.
- To explore the potential for developing effective melanoma prevention and treatment strategies.
Main Methods:
- Genetic, epidemiological, and genomic investigations.
- Validation of pathogenetic relevance in mouse models.
- Advances in rational drug design.
Main Results:
- Identification of stereotypical mutations linked to melanoma.
- Correlation of mutations with risk factors, including ultraviolet exposure.
- Optimism for future therapeutic development.
Conclusions:
- Ongoing research is uncovering key melanoma mutations and their links to risk factors.
- Mouse models and drug design advances support the development of novel melanoma therapies.
- Future prevention, diagnostics, and targeted treatments for melanoma are anticipated.
Related Concept Videos
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...